Skip to main content
. 2017 Mar 30;22(4):553. doi: 10.3390/molecules22040553

Figure 3.

Figure 3

Schematic presentation of concentration-time profile of GE phenolics following oral dose administration of 250 mg/kg GE in mice (n = 3 per time point, terminal sampling design, mean ± standard deviation (SD)). (A) Plasma pharmacokinetics without β-glucuronidase (βgd) treatment; (B) Plasma pharmacokinetics with β-glucuronidase treatment.